Pharmafile Logo
Pharmafocus logo
Advanced Search

Republicans governors retaliate against Biden vaccine mandate

November 5, 2021
Medical Communications

Republican governors are expected to sue in response to the Biden administration’s requirement that US employers ensure workers are tested …

News

Scientists identify new drug combination for children with brain cancer

November 5, 2021
Medical Communications

A new study has shown that combining two existing cancer drugs for leukaemia and melanoma could offer a promising future …

News

England COVID-19 prevalence rose to highest levels in October, study finds

November 4, 2021
Business Services

Imperial College London have said that COVID-19 rates in England rose to its highest level on record in October. This …

News

WHO grants emergency use listing to COVID vaccine

November 4, 2021
Business Services

WHO has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use in individuals aged 18 years and above. Two doses …

News

FDA fast track oral treatment of dermatitis

November 4, 2021
Business Services

UNION therapeutics have received a Fast Track designation from the FDA for their oral orismilast for the treatment of moderate …

News

HPV vaccine cutting cervical cancer rates by 87%

November 4, 2021
Business Services

The human papillomavirus (HPV) vaccine is cutting cervical cancer rates by 87% in women who were offered the vaccine between …

News
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …

Appointment

Study reveals Alzheimer’s spreads differently than previously thought

November 3, 2021
Research and Development

A University of Cambridge research team has used human data to quantify the speed of different processes that lead to …

News

Clinical trial shows promise for aggressive eye cancer treatment

November 3, 2021
Research and Development

A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy …

News

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Feature

Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment

November 3, 2021
Research and Development

Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …

News

Covid jabs more effective than virus at preventing infection

November 3, 2021
Research and Development

A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection …

News
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Appointment

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

Appointment

BioNet and BIA Separations collaborate on development of mRNA vaccines

November 2, 2021
Manufacturing and Production

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and Sartorius’ company BIA Separations, have announced the development of an …

News

Transplant patients to have mandatory full COVID vaccinations at London Health Sciences Centre

November 2, 2021
Manufacturing and Production

The Ontario-based London Health Sciences Centre’s transplant program is implementing a full COVID-19 vaccination requirement for future organ transplant recipients …

News

Dunad Therapeutics and Novartis enter partnership to develop protein therapies

November 2, 2021
Manufacturing and Production

Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to develop orally …

News

FDA approve Novartis’ Scemblix to treat leukaemia

November 2, 2021
Manufacturing and Production

Novartis have announced that the FDA approved Scemblix® (asciminib) for the treatment of chronic myeloid leukaemia (CML) in two distinct …

News

Skin patch COVID vaccine may prove more effective than injections

November 1, 2021
Sales and Marketing

A COVID vaccine skin patch is on course for its first human trial by the University of Queensland in partnership …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025